Your browser doesn't support javascript.
loading
Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
Chong, Ka Chun; Zhang, Chi; Zee, Benny Chung Ying; Luo, Tongyong; Wang, Lei; Tam, Greta Chun Huen; Jia, Katherine Min; Sun, Riyang; Wang, Maggie Haitian; Guan, Xuhua.
Afiliación
  • Chong KC; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China; Clinical Trials and Biostatistics Laboratory, Shenzhen Research Institute, The Chinese University of Hong Kong, China.
  • Zhang C; Hubei Provincial Center for Disease Control and Prevention, Hubei, China.
  • Zee BC; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China; Clinical Trials and Biostatistics Laboratory, Shenzhen Research Institute, The Chinese University of Hong Kong, China.
  • Luo T; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
  • Wang L; Hubei Provincial Center for Disease Control and Prevention, Hubei, China.
  • Tam GC; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
  • Jia KM; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
  • Sun R; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China; Clinical Trials and Biostatistics Laboratory, Shenzhen Research Institute, The Chinese University of Hong Kong, China.
  • Wang MH; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China; Clinical Trials and Biostatistics Laboratory, Shenzhen Research Institute, The Chinese University of Hong Kong, China. Electronic address: haitian.wang@gmail.com.
  • Guan X; Hubei Provincial Center for Disease Control and Prevention, Hubei, China. Electronic address: guanxh9999@163.com.
Vaccine ; 35(7): 1024-1029, 2017 02 15.
Article en En | MEDLINE | ID: mdl-28111146
Although evidence has shown that supplementary immunization activity (SIA) campaigns greatly reduce the incidence of measles, their effects on disease transmissibility have seldom been monitored. A great decrease in the number of cases may be a false signal of early success towards measles elimination to policy makers. By interpreting the transmissibility in two different post-SIA periods in Hubei, China, the current study showed sustained measles transmissions despite a reduced number of cases. Two population-based cross-sectional serological surveys of measles antibodies were conducted in Hubei province in mid-2010 and mid-2011 after the implementation of SIAs. Immunoglobulin G (IgG) antibodies against measles were measured by enzyme-linked immunosorbent assay (ELISA). Based on the estimated age-specific susceptibility levels, the effective reproduction number (R), a key indicator of disease transmissibility, was determined by the next generation matrix in transmission model. The results revealed an overall IgG seroprevalence of 88.0% (95% confidence interval [CI]: 85.6-90.4%) and 89.6% (95%CI: 88.0-91.2%), respectively, in the two different periods. Comparatively lower seroprevalence rates were observed among children less than 24months of age and young adults 15 to 19years of age in 2011. The Rs were 0.76 and 1.53 for the two study periods. In conclusion, even though the incidence was reduced to below 1/100,000 in both 2010 and 2011, the reproduction number in 2011 indicates a high risk for sustained measles transmission. This finding was potentially due to a lower seropositivity rate among young adults that had not been covered in the first SIA. Thus, implementation of SIA targeted to appropriate age groups is recommended. Regular monitoring of seroprevalence is also suggested to track disease transmissibility and to align SIA with the appropriate age groups.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacuna Antisarampión / Brotes de Enfermedades / Morbillivirus / Sarampión / Anticuerpos Antivirales Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacuna Antisarampión / Brotes de Enfermedades / Morbillivirus / Sarampión / Anticuerpos Antivirales Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: Asia Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article País de afiliación: China